TinyGemsBreaks Archive - Page 64 of 129

ThursdayJul 20, 2023 11:36 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) CEO Featured on Proactive Video Discussing LiDAR Technology and Vehicle Safety

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is spotlighted in a recent video release from Proactive. The interview includes Cepton CEO and cofounder Dr. Jun Pei talking with Proactive’s Steve Darling about how Cepton’s proprietary lidar-based solutions are revolutionizing various industries, including automotive, with its smart cities, smart spaces and smart industrial applications. Cepton is focused on making lidar technology more mainstream by offering scalable, intelligent 3D-perception solutions that achieve a balance between performance, cost and reliability. During the interview, Pei provided an overview of Cepton's approach to lidar commercialization, noting specifically the essential role…

WednesdayJul 19, 2023 3:34 pm

TinyGemsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Helius(TM) Supporting Smart City Infrastructure, Traffic Management Systems the World Over

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer of high-performance MMT(TM) lidar solutions, recently revealed that its lidar technology had been used in a series of groundbreaking studies in Texas and Utah, designed to help improve traffic safety for all road users. “The deployment of lidar technology in Arlington and Irving, Texas, as well as in Salt Lake City, Utah, has been designed to enable operators to monitor pedestrians’ walking speeds, examine pedestrian and driver adherence to road safety regulations, as well as track ‘near misses’ for pedestrians and vehicles. Going forward, lidar could help city authorities tailor traffic…

WednesdayJul 19, 2023 1:42 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its entry into definitive agreements with health care-focused institutional investors. The agreements are for the sale and issuance of 7,425,744 shares of the company’s common stock and warrants to purchase up to 7,425,744 shares of common stock at a combined offering price of $1.01 per share of common stock and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $0.885 per share, exercisable at the date of issuance…

WednesdayJul 19, 2023 12:29 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Sales Momentum with Announcement of Three New Orders

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received three new sales, for a total of eight new units. The sales, which came from a military base, a mall and a university, come on the heels of a consistent stream of orders the company has received. According to the announcement, the Nellis Air Force Base is expanding the use of K1 Retrofit Kits through a Knightscope reseller; the base has 20 competitor products that have been retrofitted with Knightscope’s modern technologies. The result is extremely cost-effective systems that utilize cellular…

WednesdayJul 19, 2023 11:58 am

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches. The company’s superior DehydraTECH processing and sublingual compositions have now been recognized through exceptional scientific study results as well as…

TuesdayJul 18, 2023 2:52 pm

TinyGemsBreaks – Bollinger Motors, a Majority-Owned EV Truck Company of Mullen Automotive Inc. (NASDAQ: MULN), Kicks off ‘Design Validation’ Pilot Builds

Bollinger Motors, which in September of 2022 became a majority-owned EV truck company of Mullen Automotive (NASDAQ: MULN), today announced the start of its “design validation” pilot builds of the B4 all-electric Class 4 chassis cabs for testing and demonstration. According to the announcement, manufacturing of the pilot vehicles has kicked off in partnership with Roush Industries Inc. at its facility in Livonia, Michigan. The first five completed chassis cabs are expected to roll out this summer, with another 15+ vehicles by the end of the third quarter of 2023. “Bollinger Motors has over eight years of experience in developing,…

TuesdayJul 18, 2023 2:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Completes Game-Changing Integration with Samsara

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility and simplicity, recently announced its new integration with Samsara, a pioneer of the Connected Operations(TM) Cloud. “Samsara’s Connected Operations Cloud has helped differentiate the company in its segment by making it easy for organizations to access, analyze and act upon real-time data from tracks, trailers, warehouses, and equipment. In turn, users have enjoyed improved safety, efficiency, and sustainability, allowing for better and even more profitable operations. With the integration, Fr8App customers can now view…

TuesdayJul 18, 2023 1:36 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has signed an exclusive license agreement with the University of Pittsburgh. The agreement grants Genprex worldwide, exclusive rights to a patent application and related technology for a gene therapy targeting both type 1 and type 2 diabetes. The therapy utilizes Pdx1 (“Pdx1”) and MafA (“MafA”) genes controlled by an MafB (“MafB”) promoter and administered through an adeno-associated virus (“AAV”) vector directly into the pancreatic duct. Preclinical data from nonhuman primate models of type 1 diabetes show promising results, with significant decreases…

TuesdayJul 18, 2023 11:59 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host Annual Meeting via Live Webcast

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that it will hold its 2023 annual meeting of stockholders (the “annual meeting”) at 1 p.m. Pacific Time on Thursday, July 20. The announcement reads, “We cordially invite everyone to attend the annual meeting, which will be held entirely online live via webcast. Visit www.meetnow.global/MMK2GSH to join the meeting live on Thursday, submit questions, and vote*. Supported browsers include Chrome, MS Edge, Firefox and Safari.” *Voting and asking questions at the meeting requires entry via a valid control number, which is…

FridayJul 14, 2023 3:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Study Reveals ‘Most Convincing Evidence’ of CBD’s Anti-Inflammatory Actions in Humans

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced additional findings from its human clinical study HYPER-H21-4, completed last year. “The hypertension study sought to evaluate DehydraTECH-processed cannabidiol (“CBD”) as a potential antihypertensive medication and already achieved primary efficacy and safety objectives. According to the company, the study also demonstrated significant reductions in several pro-inflammatory biomarkers – interleukin (‘IL’) 8, 10 and 18 – known to be linked to cardiovascular disease (‘CVD’) and many other conditions such as asthma, lung diseases, chronic kidney disease, fatty liver disease, type 1 and 2 diabetes, obesity, and rheumatoid arthritis. More specifically, after five weeks of…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks